Group B Streptococci Induce Interleukin 8 Production in Human Cervical Epithelial Cell Cultures: The Role of Capsule Polysaccharide
Group B Streptococci Induce Interleukin 8 Production in Human Cervical Epithelial Cell Cultures: The Role of Capsule Polysaccharide
Objective: Group B streptococci (GBS) are the major cause of pneumonia, sepsis, and meningitis in neonates and adults. Epithelial invasion and
___
- [1] Edwards MS, Baker CJ. Streptococcus agalactiae (Group B
Streptococcus). Mandell GL, Bennett JE, Dolin R, editors.
Mandell, Douglas, and Bennett’s Principles and Practice of
Infectious Diseases. 7th ed. Philadelphia: Churchill, Livingston,
Elsevier; 2009;2655–663.
- [2] Schuchat A. Epidemiology of group B streptococcal disease in
the United States: shifting paradigms. Clin Microbiol Rev 1998;
11:497-513.
- [3] Jones N, Oliver K, Jones Y, Haines A, Crook D. Carriage of group
B streptococcus in pregnant women from Oxford, UK. J Clin
Pathol 2006; 59:363-66.
- [4] Yılmaz Karadağ F, Hızel K, Gelişen O. Colonization of Group B
Streptococci In Pregnant Women At Delivery. J Turk Soc Obstet
Gynecol 2013; 10:16-20.
- [5] Landwehr-Kenzel S, Henneke P. Interaction of Streptococcus
agalactiae and Cellular Innate Immunity in Colonization and
Disease. Front Immunol 2014; 29:519.
- [6] Rajagopal L. Understanding the regulation of Group B
Streptococcal virulence factors. Future Microbiol 2009; 4:201-
21.
- [7] Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon
mutagenesis of type III group B Streptococcus: correlation
of capsule expression with virulence. Proc Natl Acad Sci USA
1987; 84:7208-12.
- [8] Vornhagen J, Adams Waldorf KM, Rajagopal L. Perinatal Group
B Streptococcal Infections: Virulence Factors, Immunity, and
Prevention Strategies. Trends Microbiol 2017; 25: 919-931.
- [9] Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in
the vaginal microbiome alter the innate immune response and
barrier properties of the human vaginal epithelia in a speciesspecific
manner. J Infect Dis 2014; 209:1989-99.
- [10] Palomino DC, Marti LC. Chemokines and immunity. Einstein
(Sao Paulo) 2015; 13:469-73.
- [11] Mukaida N, Harada A, Yasumoto K, Matsushima K. Properties
of pro-inflammatory cell type-specific leukocyte chemotactic
cytokines, Interleukin 8 (IL-8) and monocyte chemotactic and
activating factor (MCAF). Microbiol Immunol 1992; 36:773-89.
- [12] Guttormsen HK, Baker CJ, Edwards MS, Paoletti LC, Kasper DL.
Quantitative determination of antibodies to type III group B
streptococcal polysaccharide. J Infect Dis 1996; 173: 142-50.
- [13] Vallejo JG, Baker CJ, Edwards MS. Interleukin-6 production
by human neonatal monocytes stimulated by type III group B
streptococci. J Infect Dis 1996; 174:332-37.
- [14] Williams PA, Bohnsack JF, Augustine NH, Drummond WK,
Rubens CE, Hill HR. Production of tumor necrosis factor
by human cells in vitro and in vivo induced by group B
streptococci. J Pediatr 1993; 123:292-300.
- [15] Vallejo JG, Baker CJ, Edwards MS. Roles of the bacterial cell
wall and capsule in induction of tumor necrosis factor alpha by
type III group B streptococci. Infect Immun 1996; 64:5042-46.
- [16] Maisey HC, Doran KS, Nizet V. Recent advances in understanding
the molecular basis of group B Streptococcus virulence. Expert
Rev Mol Med 2008; 22:10:e27.